Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: AMLX) | Delayed: 28.57 -0.46 (1.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.03 | 52 Week High | $ | |||
| Open | $28.84 | 52 Week Low | $ | |||
| Day High | $30.00 | P/E | N/A | |||
| Day Low | $28.51 | EPS | $ | |||
| Volume | 1,307,962 | |||||
